Non-Viral Vector Technologies and High-Throughput Electroporation Trends
Emerging safety concerns regarding viral integration, high viral vector production bottlenecks, and advancements in non-viral delivery platforms are creating new segments within the Cell and Gene Therapy Biomanufacturing Market. High-throughput electroporation systems, lipid nanoparticles (LNPs), and transposon gene-editing platforms offer cost-effective, non-viral alternatives for cellular...
0 Commentarios 0 Acciones 196 Views 0 Vista previa